Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Seyed Hamed Hosseini Dehkordi"'
Publikováno v:
American Heart Journal Plus, Vol 27, Iss , Pp 100283- (2023)
Background: Bevacizumab is a humanized monoclonal anti-VEGF antibody often given in combination with fluorouracil-based chemotherapy as therapy for metastatic colorectal cancer (mCRC). The bleeding and thrombotic event rates in the setting of concurr
Externí odkaz:
https://doaj.org/article/d828e923676f42928d6ce0f25cdcfe62
Autor:
Moghniuddin Mohammed, Aniket S. Rali, Tyler Buechler, Venkat Vuddanda, Juwairiya Arshi, Seyed Hamed Hosseini Dehkordi, Jonathan Chandler, Robert Weidling, Travis Abicht, Nicholas Haglund, Andrew Sauer, Zubair Shah
Publikováno v:
Biomedicine Hub, Vol 5, Iss 1, Pp 1-10 (2020)
Introduction: Tricuspid valve (TV) regurgitation is the most common valvular pathology after orthotopic heart transplant (OHT). The number of transplants being performed is increasing with patients living longer after heart transplant. Data on TV sur
Externí odkaz:
https://doaj.org/article/91a354eeeb254b128f73ba4509948515
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 24 (2019)
Externí odkaz:
https://doaj.org/article/ab2a26f967d44b76b39b29b5708d947e
Impella Versus Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock
Autor:
William W. O'Neill, Navin K. Kapur, Alejandro Lemor, Jeffrey W. Moses, Mir B Basir, Pedro A. Villablanca, Gerald C. Koenig, Seyed Hamed Hosseini Dehkordi, Tarun Jain, Khaldoon Alaswad
Publikováno v:
Cardiovascular Revascularization Medicine. 21:1465-1471
Background Percutaneous ventricular assist devices and extracorporeal membrane oxygenation (ECMO) are increasingly used for mechanical circulatory support (MCS) in patients with acute myocardial infarction with cardiogenic shock (AMI-CS) in hospitals
Autor:
Davendra Mehta, Lili Chan, Claire Huang Lucas, Seyed Hamed Hosseini Dehkordi, Farid Gholitabar, Ira Meisels, Dexi Yan, Ishan Paranjpe, Xin Wei, Yumeng Wen
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 19:98-103
Electrophysiology (EP) procedures carry the risk of kidney injury due to contrast/hemodynamic fluctuations. We aim to evaluate the national epidemiology of acute kidney injury requiring dialysis (AKI-D) in patients undergoing EP procedures. Using the
Publikováno v:
Journal of Clinical Oncology. 41:104-104
104 Background: Bevacizumab is a humanized monoclonal VEGF antibody given in combination with fluorouracil-based chemotherapy for metastatic colorectal cancer (mCRC). Many patients with mCRC also have cardiovascular comorbidities requiring anticoagul
Outcomes, Temporal Trends, and Resource Utilization in Ischemic versus Nonischemic Cardiogenic Shock
Autor:
Alejandro Lemor, Seyed Hamed Hosseini Dehkordi, Hussayn Alrayes, Jennifer Cowger, Srihari S. Naidu, Pedro A. Villablanca, Mir B Basir, William O’Neill
Publikováno v:
Critical pathways in cardiology. 21(1)
Cardiogenic shock (CS) is associated with significant morbidity and mortality. Differentiating the etiologic factors driving CS has epidemiological significance and aids in optimization of therapeutic strategies, prognostication, and resource utiliza
Autor:
Tarun Dalia, Farhad Sami, Arushi Dalia, Archana Gautam, Seyed Hamed Hosseini Dehkordi, Mohamed El Khashab
Publikováno v:
Cardiology and Cardiovascular Medicine.
Autor:
Farhad, Sami, Seyed Hamed, Hosseini Dehkordi, Reza, Masoomi, Matthew, Lippmann, Hazem, Alhawasli, Stephen, Kaine, Thomas, Rosamond, Jayant, Nath, Eric, Hockstad, Peter, Tadros
Publikováno v:
The Journal of invasive cardiology. 32(8)
Autor:
Tarun Jain, James Lee, Igor F. Palacios, Marvin H. Eng, Dee Dee Wang, Gabriel A. Hernandez, Pedro A. Villablanca, William W. O'Neill, Seyed Hamed Hosseini Dehkordi, Ramandeep Mand, Vanessa Blumer, Alejandro Lemor, Mayra Guerrero
Publikováno v:
The American journal of cardiology. 127
Alcohol septal ablation (ASA) and septal myectomy (SM) are therapeutic interventions for patients with hypertrophic cardiomyopathy (HC) who remain symptomatic despite medical treatment. Outcomes for both interventions in age groups ≤65 versus65 yea